Resmed Inc. buy UBS Group AG
Start price
12.12.25
/
50%
€214.10
Target price
12.12.26
-
Performance (%)
-0.47%
Price
16:30
€213.10
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG for Resmed Inc. is nearly unchanged. This prediction currently runs until 12.12.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | -0.874% | -0.874% |
| iShares Core DAX® | -1.410% | 0.471% |
| iShares Nasdaq 100 | -0.450% | -0.305% |
| iShares Nikkei 225® | -0.224% | 5.529% |
| iShares S&P 500 | -1.095% | -0.774% |
Comments by UBS_Group_AG for this prediction
In the thread Resmed Inc. diskutieren
ResMed (NYSE:RMD) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Ratings data for RMD provided by MarketBeat